Atlas Trials

Recurrent Colon Carcinoma

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Colon Carcinoma

RecordFirmDate
Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients (NCT04213794)Mayo Clinic2019-11-08
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer (NCT04294264)Rutgers, The State University of New Jersey2019-02-12
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery (NCT03365882)SWOG Cancer Research Network2017-11-27
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060)National Cancer Institute (NCI)2015-08-17
Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer (NCT02393755)Roswell Park Cancer Institute2015-05-08
A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer (NCT01729923)University of Washington2013-03-01
Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery (NCT01802320)National Cancer Institute (NCI)2013-03-01
Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer (NCT01383343)National Cancer Institute (NCI)2011-08-01
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer (NCT01254617)National Cancer Institute (NCI)2011-02-10
Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer (NCT01198535)National Cancer Institute (NCI)2010-09-01
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (NCT01131234)National Cancer Institute (NCI)2010-05-01

Track Recurrent Colon Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.